Related Experiment Video
Updated: Jul 9, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sarcomeric proteins and inherited cardiomyopathies
1Laboratory of Clinical Pharmacology, Kyushu University Graduate School of Medicine, Fukuoka, Japan. morimoto@med.kyushu-u.ac.jp
Abstract:
Over the last two decades, a large number of mutations have been identified in sarcomeric proteins as a cause of hypertrophic, dilated or restrictive cardiomyopathy. Functional analyses of mutant proteins in vitro have revealed several important functional changes in sarcomeric proteins that might be primarily involved in the pathogenesis of each cardiomyopathy. Creation of transgenic or knock-in animals expressing mutant proteins in their hearts confirmed that these mutations in genes for sarcomeric proteins induced distinct types of cardiomyopathies and provided useful animal models to explore the molecular pathogenic mechanisms and potential therapeutics of cardiomyopathy in vivo. In this review, I discuss the functional consequences of mutations in different sarcomeric proteins found in hypertrophic, dilated, and restrictive cardiomyopathies in conjunction with their effects on cardiac structure and function in vivo and their possible molecular and cellular mechanisms, which underlie the pathogenesis of these inherited cardiomyopathies.
Insights
Mutations in sarcomeric proteins cause inherited cardiomyopathies like hypertrophic and dilated types. Animal models help study these heart diseases and develop new treatments.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Mutations in sarcomeric proteins are linked to hypertrophic, dilated, and restrictive cardiomyopathies.
- In vitro studies reveal functional changes in mutant sarcomeric proteins contributing to disease pathogenesis.
Purpose of the Study:
- To review the functional consequences of sarcomeric protein mutations in inherited cardiomyopathies.
- To discuss their impact on cardiac structure and function in vivo.
- To explore underlying molecular and cellular pathogenic mechanisms.
Main Methods:
- Review of literature on sarcomeric protein mutations and cardiomyopathies.
- Analysis of in vitro functional studies of mutant proteins.
- Examination of data from transgenic and knock-in animal models.
Main Results:
- Sarcomeric protein mutations lead to distinct cardiomyopathies.
- Mutant proteins exhibit altered function affecting cardiac structure and performance.
- Animal models confirm disease induction and provide platforms for mechanistic studies.
Conclusions:
- Understanding functional consequences of sarcomeric mutations is key to cardiomyopathy research.
- Animal models are crucial for investigating in vivo mechanisms and therapeutic strategies.
- This review synthesizes current knowledge on inherited cardiomyopathies caused by sarcomeric protein defects.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Sarcomere
Each myosin...
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

